Skip to main content
SpringerLink
Log in

NICE gives final guidance on four drugs

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. NICE. NICE says yes to dapagliflozin for some people with type 2 diabetes in final guidance. Media Release : 25 Jun 2013. Available from: URL: http://www.nice.org.uk.

  2. NICE. NICE recommends new treatment option for potentially fatal blood clotting disease. Media Release : 25 Jun 2013. Available from: URL: http://www.nice.org.uk.

  3. NICE. NICE publishes final guidance for a new treatment for enlarged spleen in adults with a rare blood cancer. Media Release : 25 Jun 2013. Available from: URL: http://www.nice.org.uk.

  4. NICE. NICE guidance on drug for severe gout. Media Release : 25 Jun 2013. Available from: URL: http://www.nice.org.uk.

  5. NICE. Breast cancer drug not cost effective for NHS, says draft NICE guidance. Media Release : 5 Jul 2013. Available from: URL: http://www.nice.org.uk.

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

NICE gives final guidance on four drugs. PharmacoEcon Outcomes News 682, 11 (2013). https://doi.org/10.1007/s40274-013-0554-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0554-8

Search

Navigation